$HLLY

Holley Inc. (HLLY): Results of Operations and Financial Condition

Holley Inc. (HLLY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 hlly-20260628xexx991.htm EX-99.1 Document Exhibit 99.1 PRESS RELEASE 1A Burton Hills Blvd, Suite 240 Nashville, TN 37215 Holley.com HOLLEY REPORTS SECOND QUARTER 2026 RESULTS DOUBLE-DIGIT CORE GROWTH IN THREE OF FOUR DIVISIONS RETURN TO NET SALES GROWTH REFLECTS STRENGT

Original reporting
Published Aug 5, 2026, 11:41 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 12:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HLLY
Bullish
high confidence
Mentioned
$HLLY
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HLLYBullishMed
01

Why it matters

The key tradable elements are the Q2 operating/cash metrics, the portfolio rebalancing progress (non-core Restoration brands sold), and the reiterated full-year guidance alongside continued debt reduction toward a 3.5x leverage target.

02

Market read

Holley’s Q2 print combines modest top-line growth, higher adjusted net income and free cash flow, and ongoing leverage reduction, while Adjusted EBITDA margin fell and a non-core sale loss weighed on GAAP results.

03

What to watch

The filing notes a prior-year one-time non-cash tariff capitalization benefit that did not repeat, which can make year-over-year Adjusted EBITDA comparisons look flatter than GAAP earnings quality; traders should also watch whether core growth sustains into H2 given the margin pressure.

Relevance 7/10Novelty 8/10Timing: pre-market today, Q2 results and full-year guidance reiterated in an 8-K

Background

Holley filed an SEC 8-K (Item 2.02) with its Q2 2026 results press release and full-year 2026 outlook.

Company-level read

Ticker impact

$HLLYBullishHigh confidence
Context

Holley reported Q2 2026 results with net sales up 3.2% and reiterated full-year core revenue and Adjusted EBITDA guidance.

Expected impact

Likely near-term positive bias as guidance is reiterated and leverage continues to trend down, offset by margin compression and lower Adjusted EBITDA.

Evidence & confidence

The filing includes specific Q2 datapoints (net sales, adjusted net income, free cash flow) plus a reiterated full-year outlook and concrete debt prepayment/leverage progress, which are direct drivers for valuation and risk.

Market effects

Automotive aftermarket names may see read-across from Holley’s portfolio rebalancing and cash/leverage focus, but this is company-specific.

No clear regional spillover beyond US-listed small/mid-cap industrial/auto aftermarket sentiment.

Limited global relevance; impacts are primarily within the US aftermarket performance-parts ecosystem.

Counterpoint

Adjusted EBITDA and margin declined year over year, and the quarter included a large non-core asset sale loss, so investors may question underlying operating momentum.

Key entities

  • Holley Inc.

    NYSE-listed automotive aftermarket performance solutions provider reporting Q2 2026 results and reiterating 2026 guidance.

  • Matthew Stevenson

    CEO quoted on core growth momentum and second-half launch/retailer placement cadence.

  • Jesse Weaver

    CFO quoted on cash generation, leverage reduction, and Adjusted EBITDA comparison adjustments.

Related articles

$IQMed

Form Video Industry Growth Logic Transformation in the AI Era

iQIYI reported Q2 2026 revenue of RMB 6.29 billion, with membership and advertising services contributing RMB 4.01 billion and RMB 1.25 billion, respectively. Non-GAAP operating loss narrowed. Key highlights include positive operating cash flow, 56% YoY growth in content distribution revenue, AI business progress, and 40% YoY growth in overseas membership revenue. The company is undergoing strategic transformation, focusing on AI and decentralization.

$SPGMedAI 8/10

Why Simon Property Group’s malls are attracting more retailers

Simon Property Group reported strong Q2 results with revenue up 20% to $1.79B. CEO Eli Simon noted high retailer demand, 1,200 leases signed, and 17% positive rent spreads. Portfolio occupancy remained at 96%, with re-leased Saks Off 5th space expected to yield higher rents. FFO was flat at $1.185B, while net income decreased 13.1% to $483.1M. Sales productivity rose 14% to $838 per sq ft.

$GILDHighAI 8/10

Gilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?

Gilead Sciences (GILD) reported Q2 2026 with double-digit growth in commercial portfolio sales, but posted a significant loss due to $11.2B in R&D expenses from acquisitions. HIV sales rose 12% to $5.7B, while non-HIV areas like liver disease and cancer treatments also showed growth. The company raised its 2026 sales guidance and made strategic acquisitions, but faces risks from clinical development and financial obligations.

$ABBVMedAI 8/10

AbbVie’s Humira Replacement Strategy Is Working, But Could Growth Be Too Concentrated?

AbbVie (NYSE:ABBV) reported Q2 2026 revenue of $16.99B, up 10.2%, driven by immunology and neuroscience. Skyrizi and Rinvoq revenues grew 24.4% and 24.5% respectively, offsetting Humira's 35.9% decline. However, concentration risk exists as these two products made up 47% of revenue. Oncology and aesthetics showed weaker performance, with oncology revenue down 1.5%. Adjusted EPS rose 22.9% to $3.65.